Newsletter | April 6, 2026

04.06.26 -- Optimizing Process Development Through Upstream And Downstream Integration

FOCUS ON UPSTREAM MANUFACTURING

Optimizing Process Development Through Upstream And Downstream Integration

This interactive panel discussion explored how upstream and downstream development teams can work together to reduce risk, accelerate process scaling, and support smoother downstream tech transfer.

Streamline Your AAV Process With A Production Platform

AAVs are reshaping gene therapy, but scaling production introduces complexity. Learn how upstream process optimization can improve yield, consistency, and speed to meet growing demands.

Stable Bulk Cultures: A Fast Path To Antibody Manufacturing

The potential advantages that stable bulk cultures can offer a drug development paradigm are poised to accelerate and bolster biopharmaceutical clinical manufacturing.

Improving The Efficacy Of T Cell Therapies

CAR-T cell therapy is evolving rapidly, with scientists exploring new ways to improve efficacy, safety, and applicability. Precision media formulation plays a key role in optimizing therapeutic cell quality.

Cell Collection Basics For The Transplant And CGT Industries

Breakthroughs in CAR T-cell and stem cell therapies depend on mastering cellular collection. Understanding these fundamentals is vital for advancing treatment efficacy and patient outcomes.

mRNA Manufacturing With Fed-Batch In Vitro Transcription

A milliliter-scale approach to IVT optimization reveals how controlled feeding, precise pH management, and real-time monitoring can boost mRNA yield and streamline scale-up to larger bioreactor volumes.

Phototrophic Cultivation Of Chlorella vulgaris In Microbioreactors

Unlock efficient microalgae cultivation with precise lighting and real-time insights. Discover ways to boost biomass, optimize growth, and accelerate sustainable bioenergy and bioproduct innovation.

Cell Harvesting: A Strategic Lever In Allogeneic Therapy Production

Current cell harvest techniques in allogeneic manufacturing face limitations, including scalability issues and cell damage. See why a shift in approach is vital for high-quality, efficient production at scale.

Advancing Gene Editing With Enhanced Post-Electroporation Performance

Non-viral gene editing is a powerful method for cell therapy. Find out how to address key challenges like cell viability and thermal damage with an innovative approach designed to improve performance.

SPONSOR

Webinar: Defined Media, Defined Results: Scaling E. coli from Bench to Fermenter

Microbial systems power plasmid DNA and recombinant protein production, but scaling introduces variability. This webinar explores how chemically defined media can improve performance, reproducibility, and animal-origin-free workflows. Experts share beta-test results from E. coli cultures using defined formulations, plus practical insights on integrating them into workflows and scaling from experiments to fermenter production for reliable manufacturing outcomes. Click here to learn more.

UPSTREAM MANUFACTURING SOLUTIONS

Maintaining Contamination-Free Cell Cultures In Open-Vessel Cultivation - INFORS HT

Phosphitylating And Phosphorylating Agents - Entegris, Inc.

Eliminate The Need For GMP Plasmids - Asimov

Performance-Optimized Solutions For MSC Expansion - FUJIFILM Biosciences

Connect With Bioprocess Online: